Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tabalumab
BIOLOGICAL
2 trials
Sponsors
Eli Lilly and Company
Conditions
Multiple Myeloma
Phase 1
Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma
Completed
NCT01556438
Eli Lilly and Company
Multiple Myeloma
Start: 2012-07-31
End: 2015-08-31
Updated: 2019-03-20
Phase 2
A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)
Completed
NCT01602224
Eli Lilly and Company
Multiple Myeloma
Start: 2012-07-31
End: 2014-07-31
Updated: 2019-10-08
Related Papers
Dose‐escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma
Cancer Science
2016-06-28
12 citations